Anti-Kv7.3 (KCNQ3, potassium voltage-gated channel, KQT-like subfamily, member 3, BFNC2, EBN2, KQT-l

Anti-Kv7.3 (KCNQ3, potassium voltage-gated channel, KQT-like subfamily, member 3, BFNC2, EBN2, KQT-l
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
K0138-04.100 100 µg - -

3 - 19 Werktage*

516,00 €
 
The M channel is a slowly activating and deactivating potassium channel that plays a critical... mehr
Produktinformationen "Anti-Kv7.3 (KCNQ3, potassium voltage-gated channel, KQT-like subfamily, member 3, BFNC2, EBN2, KQT-l"
The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and one of two related proteins encoded by the KCNQ2 and KCNQ5 genes, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: ELISA: 1:16000, Western Blot: 0.3ug/ml , Optimal dilutions to be determined by the researcher. Positive Control: Human Brain (Cerebral Cortex, Amygdala, Hippocampus) lysates , Storage and Stability: May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 monthsat -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Peptide Blocking: Corresponding peptide is available for Peptide Blocking studies. See K0138-04-P. Antibody is typically 0.5mg/ml and peptide is supplied as a 100ul pellet. When peptide is reconstituted in 200ul water, the concentration would also be 0.5mg/ml. To start, the best ratio would be 1:1 (molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. It is best is to have two identical blots to be incubated with equal amount of antibody, but one with the antibody pre-adsorbed to the peptide for 20min. Then incubate and develop the two blots in parallel.
Schlagworte: Anti-Potassium channel subunit alpha KvLQT3, Anti-Voltage-gated potassium channel subunit Kv7.3, Anti-Potassium voltage-gated channel subfamily KQT member 3
Hersteller: United States Biological
Hersteller-Nr: K0138-04

Eigenschaften

Anwendung: ELISA, WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Goat
Spezies-Reaktivität: human
Immunogen: Synthetic peptide, C-SDSVWTPSNKPI, from the C-Terminus of human KCNQ3.
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Kv7.3 (KCNQ3, potassium voltage-gated channel, KQT-like subfamily, member 3, BFNC2, EBN2, KQT-l"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen